Correction to: CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:72 |
---|---|
Enthalten in: |
Cancer immunology immunotherapy - 72(2023), 7 vom: 08. Mai, Seite 2513-2514 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Marcinek, Anetta [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: |
---|
Anmerkungen: |
© The Author(s) 2023 |
---|
doi: |
10.1007/s00262-023-03457-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2143839243 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | OLC2143839243 | ||
003 | DE-627 | ||
005 | 20240118092015.0 | ||
007 | tu | ||
008 | 240118s2023 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s00262-023-03457-9 |2 doi | |
035 | |a (DE-627)OLC2143839243 | ||
035 | |a (DE-He213)s00262-023-03457-9-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.00 |2 bkl | ||
100 | 1 | |a Marcinek, Anetta |e verfasserin |4 aut | |
245 | 1 | 0 | |a Correction to: CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © The Author(s) 2023 | ||
700 | 1 | |a Brauchle, Bettina |4 aut | |
700 | 1 | |a Rohrbacher, Lisa |4 aut | |
700 | 1 | |a Hänel, Gerulf |4 aut | |
700 | 1 | |a Philipp, Nora |4 aut | |
700 | 1 | |a Märkl, Florian |4 aut | |
700 | 1 | |a Strzalkowski, Thaddäus |4 aut | |
700 | 1 | |a Lacher, Sonja M. |4 aut | |
700 | 1 | |a Udiljak, Dragica |4 aut | |
700 | 1 | |a Spiekermann, Karsten |4 aut | |
700 | 1 | |a Theurich, Sebastian |4 aut | |
700 | 1 | |a Kobold, Sebastian |4 aut | |
700 | 1 | |a Kischel, Roman |4 aut | |
700 | 1 | |a James, John R. |4 aut | |
700 | 1 | |a Bücklein, Veit L. |4 aut | |
700 | 1 | |a Subklewe, Marion |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer immunology immunotherapy |d Springer Berlin Heidelberg, 1976 |g 72(2023), 7 vom: 08. Mai, Seite 2513-2514 |w (DE-627)129442712 |w (DE-600)195342-4 |w (DE-576)014812193 |x 0340-7004 |7 nnns |
773 | 1 | 8 | |g volume:72 |g year:2023 |g number:7 |g day:08 |g month:05 |g pages:2513-2514 |
856 | 4 | 1 | |u https://doi.org/10.1007/s00262-023-03457-9 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_4277 | ||
936 | b | k | |a 44.00 |q VZ |
951 | |a AR | ||
952 | |d 72 |j 2023 |e 7 |b 08 |c 05 |h 2513-2514 |